Table 4.
Overall average costs (2013 USD) and utilization by cancer type for patients with FNH
| Costs and utilization, mean (95% CI) |
Emergency department visit |
Hospitalization stay |
Office-based visit | Totalb | ||
|---|---|---|---|---|---|---|
|
| ||||||
| All-cause | Oncology | Oncology without chemotherapy |
||||
| Breast cancer (n = 459) | ||||||
| Costs, $ | 1215 (1131–1295) | 16,940 (15,689–18,590) | 2317 (2199–2451) | 1831 (1737–1938) | 504 (331–611) | 20,462 (19,072–22,181) |
| Visitan | 1.2 (1.2–1.3) | 4.1 (3.7–4.5) | 3.9 (3.7–4.2) | 2.2 (2.0–2.4) | 1.1 (0.9–1.2) | 6.3 (6.0–6.7) |
| Lung cancer (n = 115) | ||||||
| Costs, $ | 1422 (1264–1611) | 28,413 (23,686–34,536) | 3126 (2617–3787) | 2505 (2080–3063) | 450 (331–611) | 32,964 (28,166–39,278) |
| Visitan | 1.2 (1.1–1.3) | 6.8 (5.7–8.3) | 5.3 (4.3–6.7) | 2.7 (2.2–3.3) | 0.9 (0.7–1.3) | 7.7 (6.6–9.2) |
| NHL (n = 130) | ||||||
| Costs, $ | 1729 (1520–1970) | 33,006 (27,628–39,382) | 2813 (2522–3153) | 2209 (1965–2497) | 834 (658–1049) | 37,555 (32,060–44,174) |
| Visitan | 1.5 (1.3–1.7) | 7.9 (6.7–9.5) | 5.3 (4.6–6.0) | 2.9 (2.5–3.4) | 1.8 (1.4–2.2) | 8.2 (7.4–9) |
a
Hospitalization stays are indicated as bootstrapped mean (95% CI) LOS in days; all other visits are indicated as bootstrapped mean (95% CI) number of visits
b
Total visits is the sum of emergency department visits + hospitalization stays + outpatient visits divided by the cycle-specific sample (n); total costs is the sum of emergency department costs + hospitalization costs + outpatient costs divided by the cycle-specific sample (n)